Literature DB >> 7695312

Relationship between structure and convulsant properties of some beta-lactam antibiotics following intracerebroventricular microinjection in rats.

A De Sarro1, D Ammendola, M Zappala, S Grasso, G B De Sarro.   

Abstract

The epileptogenic activities of several beta-lactam antibiotics were compared following their intracerebroventricular administration in rats. Different convulsant potencies were observed among the various beta-lactam antibiotics tested, but the epileptogenic patterns were similar. The patterns consisted of an initial phase characterized by wet-dog shakes followed by head tremor, nodding, and clonic convulsions. After the largest doses of beta-lactam antibiotics injected, clonus of all four limbs and/or the trunk, rearing, jumping, falling down, escape response, transient tonic-clonic seizures, and sometimes generalized seizures were observed, followed by a postictal period with a fatal outcome. At a dose of 0.033 mumol per rat, cefazolin was the most powerful epileptogenic compound among the drugs tested. It was approximately three times more potent than benzylpenicillin in generating a response and much more potent than other cephalosporins, such as ceftriaxone, cefoperazone, and cefamandole. No epileptogenic signs were observed with equimolar doses of cefotaxime, cefonicid, cefixime, and ceftizoxime in this model. The more convulsant compounds (i.e., cefazolin and ceftezole) are both characterized by the presence of a tetrazole nucleus at position 7 and show a marked chemical similarity to pentylenetetrazole. Imipenem and meropenem, the two carbapenems tested, also showed epileptogenic properties, but imipenem was more potent than meropenem, with a convulsant potency similar to those of ceftezole and benzylpenicillin. In addition, the monobactam aztreonam possessed convulsant properties more potent than those of cefoperazone and cefamandole. This suggest that the beta-lactam ring is a possible determinant of production of epileptogenic activity, with likely contributory factors in the substitutions at the 7-aminocephalosporanic or 6-aminopenicillanic acid that may increase or reduce the epileptogenic properties of the beta-lactam antibiotics. While the structure-activity relationship was also investigated, there seem to be no convincing correlations among the rank order of lipophilicities and the convulsant potencies of the compounds studied. The lack of marked convulsant properties of cefixime, cefonicid, cefuroxime, and cephradine suggests that these antibiotics may interact with a binding site which is different from that by which the beta-lactam antibiotics exert their convulsant effects or may demonstrate a reduced affinity for the relevant site(s).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7695312      PMCID: PMC162514          DOI: 10.1128/AAC.39.1.232

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  In vitro activity of Ro 23-9424, a dual-action cephalosporin, compared with activities of other antibiotics.

Authors:  J W Gu; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

2.  Animal model for evaluating the convulsive liability of beta-lactam antibiotics.

Authors:  P D Williams; D B Bennett; C R Comereski
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

3.  Generalized penicillin epilepsy in the cat: effects of intracarotid and intravertebral pentylenetetrazol and amobarbital injections.

Authors:  P Gloor; G Testa
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1974-05

4.  Convulsive action of penicillin.

Authors:  D R Curtis; C J Game; G A Johnston; R M McCulloch; R M MacLachlan
Journal:  Brain Res       Date:  1972-08-11       Impact factor: 3.252

5.  Neurotoxicity of intravenously administered penicillin G.

Authors:  M E Raichle; H Kutt; S Louis; F McDowell
Journal:  Arch Neurol       Date:  1971-09

6.  Comparative convulsant activity of various penicillins after intracerebral injection in mice.

Authors:  M C Gerald; J Massey; D C Spadaro
Journal:  J Pharm Pharmacol       Date:  1973-02       Impact factor: 3.765

7.  Meropenem: evidence of lack of proconvulsive tendency in mice.

Authors:  J B Patel; R E Giles
Journal:  J Antimicrob Chemother       Date:  1989-09       Impact factor: 5.790

8.  Seizure propensity with imipenem.

Authors:  R H Eng; A N Munsif; B G Yangco; S M Smith; H Chmel
Journal:  Arch Intern Med       Date:  1989-08

Review 9.  An overview of the pharmacology of imipenem/cilastatin.

Authors:  G L Drusano
Journal:  J Antimicrob Chemother       Date:  1986-12       Impact factor: 5.790

10.  Seizures in patients simultaneously receiving theophylline and imipenem or ciprofloxacin or metronidazole.

Authors:  J D Semel; N Allen
Journal:  South Med J       Date:  1991-04       Impact factor: 0.954

View more
  17 in total

1.  Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of imipenem in healthy rats.

Authors:  A Dupuis; W Couet; J Paquereau; S Debarre; A Portron; C Jamois; S Bouquet
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Reversible encephalopathy induced by cefoperazone: a case report monitored with EEG.

Authors:  Stefano Pro; F Randi; P Pulitano; E Vicenzini; O Mecarelli
Journal:  Neurol Sci       Date:  2010-10-07       Impact factor: 3.307

3.  A periodic density functional theory study of tetrazole adsorption on anatase surfaces: potential application of tetrazole rings in dye-sensitized solar cells.

Authors:  Alireza Najafi Chermahini; Behzad Hosseinzadeh; Alireza Salimi Beni; Abbas Teimouri; Mahmood Moradi
Journal:  J Mol Model       Date:  2014-02-13       Impact factor: 1.810

Review 4.  Intrathecal Antibacterial and Antifungal Therapies.

Authors:  Roland Nau; Claudia Blei; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2020-04-29       Impact factor: 26.132

Review 5.  Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.

Authors:  Roland Nau; Fritz Sörgel; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

6.  Prospective, randomised, multicentre study of meropenem versus imipenem/cilastatin as empiric monotherapy in severe nosocomial infections.

Authors:  J Garau; J Blanquer; L Cobo; S Corcia; M Daguerre; F J de Latorre; C León; F Del Nogal; A Net; J Rello
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-11       Impact factor: 3.267

7.  Non-convulsive status epilepticus following antibiotic therapy as a cause of unexplained loss of consciousness in patients with renal failure.

Authors:  Savas Ozturk; Gonenc Kocabay; Baris Topcular; Halil Yazici; Arif Atahan Cagatay; Gulistan Bahat; Betul Baykan; Aydin Turkmen; Alaattin Yildiz
Journal:  Clin Exp Nephrol       Date:  2008-12-17       Impact factor: 2.801

Review 8.  Clinical pharmacokinetics of antibacterials in cerebrospinal fluid.

Authors:  Antonello Di Paolo; Giovanni Gori; Carlo Tascini; Romano Danesi; Mario Del Tacca
Journal:  Clin Pharmacokinet       Date:  2013-07       Impact factor: 6.447

Review 9.  Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.

Authors:  L R Wiseman; A J Wagstaff; R N Brogden; H M Bryson
Journal:  Drugs       Date:  1995-07       Impact factor: 9.546

10.  Ceftiaxone-induced neurotoxicity: case report, pharmacokinetic considerations, and literature review.

Authors:  Ki Bae Kim; Sun Moon Kim; Woori Park; Ji Seon Kim; Soon Kil Kwon; Hye-Young Kim
Journal:  J Korean Med Sci       Date:  2012-08-22       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.